These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38574400)

  • 21. Medial Temporal Atrophy in Amyloid-Negative Amnestic Type Dementia Is Associated with High Cerebral White Matter Hyperintensity.
    Wong BYX; Yong TT; Lim L; Tan JY; Ng ASL; Ting SKS; Hameed S; Ng KP; Zhou JH; Kandiah N
    J Alzheimers Dis; 2019; 70(1):99-106. PubMed ID: 31177215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
    Edwards L; Thomas KR; Weigand AJ; Edmonds EC; Clark AL; Walker KS; Brenner EK; Nation DA; Maillard P; Bondi MW; Bangen KJ;
    J Alzheimers Dis; 2023; 94(2):695-707. PubMed ID: 37302031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change.
    Fiford CM; Sudre CH; Pemberton H; Walsh P; Manning E; Malone IB; Nicholas J; Bouvy WH; Carmichael OT; Biessels GJ; Cardoso MJ; Barnes J;
    Neuroinformatics; 2020 Jun; 18(3):429-449. PubMed ID: 32062817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study.
    Wang J; Ackley S; Woodworth DC; Sajjadi SA; Decarli CS; Fletcher EF; Glymour MM; Jiang L; Kawas C; Corrada MM
    Neurology; 2024 Aug; 103(3):e209665. PubMed ID: 39008782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Interaction Between Vascular Risk Factors, Cerebral Small Vessel Disease, and Amyloid Burden in Older Adults.
    Koncz R; Wen W; Makkar SR; Lam BCP; Crawford JD; Rowe CC; Sachdev P;
    J Alzheimers Dis; 2022; 86(4):1617-1628. PubMed ID: 35213365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.
    McAleese KE; Miah M; Graham S; Hadfield GM; Walker L; Johnson M; Colloby SJ; Thomas AJ; DeCarli C; Koss D; Attems J
    Acta Neuropathol; 2021 Dec; 142(6):937-950. PubMed ID: 34608542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
    Dewenter A; Jacob MA; Cai M; Gesierich B; Hager P; Kopczak A; Biel D; Ewers M; Tuladhar AM; de Leeuw FE; Dichgans M; Franzmeier N; Duering M;
    Brain; 2023 Feb; 146(2):678-689. PubMed ID: 35859352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
    Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
    J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.
    McAleese KE; Graham S; Dey M; Walker L; Erskine D; Johnson M; Johnston E; Thomas AJ; McKeith IG; DeCarli C; Attems J
    Brain Pathol; 2019 May; 29(3):414-424. PubMed ID: 30485582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.
    Bergkamp MI; Tuladhar AM; van der Holst HM; van Leijsen EMC; Ghafoorian M; van Uden IWM; van Dijk EJ; Norris DG; Platel B; Esselink RAJ; Leeuw FE
    Parkinsonism Relat Disord; 2019 Apr; 61():94-100. PubMed ID: 30448096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage.
    Joseph-Mathurin N; Feldman RL; Lu R; Shirzadi Z; Toomer C; Saint Clair JR; Ma Y; McKay NS; Strain JF; Kilgore C; Friedrichsen KA; Chen CD; Gordon BA; Chen G; Hornbeck RC; Massoumzadeh P; McCullough AA; Wang Q; Li Y; Wang G; Keefe SJ; Schultz SA; Cruchaga C; Preboske GM; Jack CR; Llibre-Guerra JJ; Allegri RF; Ances BM; Berman SB; Brooks WS; Cash DM; Day GS; Fox NC; Fulham M; Ghetti B; Johnson KA; Jucker M; Klunk WE; la Fougère C; Levin J; Niimi Y; Oh H; Perrin RJ; Reischl G; Ringman JM; Saykin AJ; Schofield PR; Su Y; Supnet-Bell C; Vöglein J; Yakushev I; Brickman AM; Morris JC; McDade E; Xiong C; Bateman RJ; Chhatwal JP; Benzinger TLS;
    Alzheimers Dement; 2024 Apr; 20(4):2680-2697. PubMed ID: 38380882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume.
    van Rooden S; van den Berg-Huysmans AA; Croll PH; Labadie G; Hayes JM; Viviano R; van der Grond J; Rombouts SARB; Damoiseaux JS
    J Alzheimers Dis; 2018; 66(3):1283-1294. PubMed ID: 30412485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Loss of Integrity of the Cingulum Bundle Link Amyloid-β Accumulation and Neurodegeneration in Alzheimer's Disease?
    Vlegels N; Ossenkoppele R; van der Flier WM; Koek HL; Reijmer YD; Wisse LE; Biessels GJ;
    J Alzheimers Dis; 2022; 89(1):39-49. PubMed ID: 35848018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers.
    Hilal S; Ikram MA; Verbeek MM; Franco OH; Stoops E; Vanderstichele H; Niessen WJ; Vernooij MW
    Stroke; 2018 Nov; 49(11):2692-2698. PubMed ID: 30355213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients.
    Biesbroek JM; Coenen M; DeCarli C; Fletcher EM; Maillard PM; ; Barkhof F; Barnes J; Benke T; Chen CPLH; Dal-Bianco P; Dewenter A; Duering M; Enzinger C; Ewers M; Exalto LG; Franzmeier N; Hilal S; Hofer E; Koek HL; Maier AB; McCreary CR; Papma JM; Paterson RW; Pijnenburg YAL; Rubinski A; Schmidt R; Schott JM; Slattery CF; Smith EE; Sudre CH; Steketee RME; Teunissen CE; van den Berg E; van der Flier WM; Venketasubramanian N; Venkatraghavan V; Vernooij MW; Wolters FJ; Xin X; Kuijf HJ; Biessels GJ
    Alzheimers Dement; 2024 Apr; 20(4):2980-2989. PubMed ID: 38477469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White matter hyperintensities influence distal cortical β-amyloid accumulation in default mode network pathways.
    Ali DG; Bahrani AA; El Khouli RH; Gold BT; Jiang Y; Zachariou V; Wilcock DM; Jicha GA
    Brain Behav; 2023 Oct; 13(10):e3209. PubMed ID: 37534614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders.
    Kim YE; Lim JS; Suh CH; Heo H; Roh JH; Cheong EN; Lee Y; Kim JW; Lee JH
    Alzheimers Res Ther; 2024 Aug; 16(1):185. PubMed ID: 39148136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study.
    Bernal J; Schreiber S; Menze I; Ostendorf A; Pfister M; Geisendörfer J; Nemali A; Maass A; Yakupov R; Peters O; Preis L; Schneider L; Herrera AL; Priller J; Spruth EJ; Altenstein S; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Rostamzadeh A; Glanz W; Buerger K; Janowitz D; Ewers M; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Laske C; Munk MH; Spottke A; Roy N; Dobisch L; Dechent P; Scheffler K; Hetzer S; Wolfsgruber S; Kleineidam L; Schmid M; Berger M; Jessen F; Wirth M; Düzel E; Ziegler G
    Alzheimers Res Ther; 2023 May; 15(1):97. PubMed ID: 37226207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions.
    Weaver NA; Doeven T; Barkhof F; Biesbroek JM; Groeneveld ON; Kuijf HJ; Prins ND; Scheltens P; Teunissen CE; van der Flier WM; Biessels GJ;
    Neurobiol Aging; 2019 Dec; 84():225-234. PubMed ID: 31500909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.